… embolectomy) for people with acute pulmonary embolism (PE). We did not include trials that
compared two different thrombolytic agents or different doses of the same thrombolytic drug. …

… of thrombolytic therapy for the treatment of acute pulmonary embolism (PE) 1,2 its indications
still remain uncertain. The most widely accepted indication for thrombolytic therapy for PE …

… of thrombolysis in … thrombolytic therapies in the treatment of PE with and without hemodynamic
instability. In addition, we intend to determine the optimal regimen of thrombolytic therapy …

… of pulmonary hypertension. Finally, through all of these mechanisms, thrombolytic therapy
… and systematic review of studies evaluating thrombolytic therapy of patients with PE. Based …

… and safety of thrombolytic therapy in patients with an acute pulmonary embolism (PE). …
Nevertheless, because of its rapid effect on pulmonary vascular resistance, thrombolytic treatment …

… as follows: objective assessment of thrombolysis; all-cause … Crude analysis of summated
data on thrombolytic efficacy from all … suggests that the three thrombolytic agents may vary in …

… of death in patients with intermediate-risk pulmonary embolism who were randomized to
tenecteplase versus placebo in the PEITHO (Pulmonary Embolism Thrombolysis) trial. A total of …

… Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with acute
pulmonary embolism (PE… We reviewed the risks and benefits of thrombolytic therapy in the …

… Thrombolytic therapy accelerates the dissolution of acute pulmonary embolism and is … The
goal of this article is to offer a critical analysis of the use of thrombolytic therapy in this setting. …

… inadequate embolic resolution. Thrombolytic therapy of the initial pulmonary embolic episode
… Since almost all pulmonary emboli originate in the deep venous system of the legs, the …